Literature DB >> 8557028

A highly recombinogenic system for the recovery of infectious Sendai paramyxovirus from cDNA: generation of a novel copy-back nondefective interfering virus.

D Garcin1, T Pelet, P Calain, L Roux, J Curran, D Kolakofsky.   

Abstract

We have recovered infectious Sendai virus (SeV) from full-length cDNA (FL-3) by transfecting this cDNA and pGEM plasmids expressing the nucleocapsid protein (NP), phosphoprotein and large proteins into cells infected with a vaccinia virus which expresses T7 RNA polymerase. These cells were then injected into chicken eggs, in which SeV grows to very high titers. FL-3 was marked with a BglII site in the leader region and an NsiI site (ATGCAT) in the 5' nontranslated region of the NP gene, creating a new, out-of-frame, 5' proximal AUG. All the virus stocks generated eventually removed this impediment to NP expression, by either point mutation or recombination between FL-3 and pGEM-NP. The recovery system was found to be highly recombinogenic. Even in the absence of selective pressure, one in 20 of the recombinant SeV generated had exchanged the NP gene of FL-3 with that of pGEM-NP. When a fifth plasmid containing a new genomic 3' end without the presumably deleterious BglII site was included as another target for recombination, the new genomic 3' end was found in the recombinant SeV in 12 out of 12 recoveries. Using this approach, a novel copy-back nondefective virus was generated which interferes with wild-type virus replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8557028      PMCID: PMC394733          DOI: 10.1002/j.1460-2075.1995.tb00299.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  30 in total

1.  Ends of the RNA within Sendai virus defective interfering nucleocapsids are not free.

Authors:  S Lynch; D Kolakofsky
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

2.  Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase.

Authors:  T R Fuerst; E G Niles; F W Studier; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins.

Authors:  T Shioda; K Iwasaki; H Shibuta
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

4.  Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene.

Authors:  Y Hidaka; T Kanda; K Iwasaki; A Nomoto; T Shioda; H Shibuta
Journal:  Nucleic Acids Res       Date:  1984-11-12       Impact factor: 16.971

5.  the relationship of conformational changes in the Sendai virus nucleocapsid to proteolytic cleavage of the NP polypeptide.

Authors:  M H Heggeness; A Scheid; P W Choppin
Journal:  Virology       Date:  1981-10-30       Impact factor: 3.616

6.  Cloned poliovirus complementary DNA is infectious in mammalian cells.

Authors:  V R Racaniello; D Baltimore
Journal:  Science       Date:  1981-11-20       Impact factor: 47.728

7.  Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins.

Authors:  T Shioda; Y Hidaka; T Kanda; H Shibuta; A Nomoto; K Iwasaki
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

8.  Recombinant vesicular stomatitis viruses from DNA.

Authors:  N D Lawson; E A Stillman; M A Whitt; J K Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  Fidelity of homologous recombination in vaccinia virus DNA.

Authors:  L A Ball
Journal:  Virology       Date:  1995-06-01       Impact factor: 3.616

10.  Rescue of measles viruses from cloned DNA.

Authors:  F Radecke; P Spielhofer; H Schneider; K Kaelin; M Huber; C Dötsch; G Christiansen; M A Billeter
Journal:  EMBO J       Date:  1995-12-01       Impact factor: 11.598

View more
  84 in total

1.  The versatility of paramyxovirus RNA polymerase stuttering.

Authors:  S Hausmann; D Garcin; C Delenda; D Kolakofsky
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 2.  Reverse genetics of negative-strand RNA viruses: closing the circle.

Authors:  A Pekosz; B He; R A Lamb
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

3.  Rescue of rabies virus from cloned cDNA and identification of the pathogenicity-related gene: glycoprotein gene is associated with virulence for adult mice.

Authors:  N Ito; M Takayama; K Yamada; M Sugiyama; N Minamoto
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  "Rule of six": how does the Sendai virus RNA polymerase keep count?

Authors:  D Vulliémoz; L Roux
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  The temperature-sensitive (ts) phenotype of a cold-passaged (cp) live attenuated respiratory syncytial virus vaccine candidate, designated cpts530, results from a single amino acid substitution in the L protein.

Authors:  K Juhasz; S S Whitehead; P T Bui; J M Biggs; J E Crowe; C A Boulanger; P L Collins; B R Murphy
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

6.  Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells.

Authors:  W Chehadeh; J Kerr-Conte; F Pattou; G Alm; J Lefebvre; P Wattré; D Hober
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape.

Authors:  H Jin; G P Leser; J Zhang; R A Lamb
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

8.  Given the opportunity, the Sendai virus RNA-dependent RNA polymerase could as well enter its template internally.

Authors:  Diane Vulliémoz; Laurent Roux
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Codon substitution mutations at two positions in the L polymerase protein of human parainfluenza virus type 1 yield viruses with a spectrum of attenuation in vivo and increased phenotypic stability in vitro.

Authors:  Josephine M McAuliffe; Sonja R Surman; Jason T Newman; Jeffrey M Riggs; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

10.  Involvement of the leader sequence in Sendai virus pathogenesis revealed by recovery of a pathogenic field isolate from cDNA.

Authors:  Yutaka Fujii; Takemasa Sakaguchi; Katsuhiro Kiyotani; Cheng Huang; Noriko Fukuhara; Yoshiko Egi; Tetsuya Yoshida
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.